549 related articles for article (PubMed ID: 8848709)
1. [Heart, brain and hypertension].
Lüscher TF; Sturzenegger M; Noll G
Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
[TBL] [Abstract][Full Text] [Related]
2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
5. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
6. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive drugs: diuretics and betablockers are the best assessed.
Prescrire Int; 1999 Jun; 8(41):90-5. PubMed ID: 10558453
[TBL] [Abstract][Full Text] [Related]
8. [Hypertension as a function of age].
Gensini GF; Corradi F
Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
[TBL] [Abstract][Full Text] [Related]
9. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
10. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of cerebrovascular circulatory disorders].
Herrschaft H
Fortschr Neurol Psychiatr; 1985 Sep; 53(9):337-43. PubMed ID: 4043914
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hypertension and cardiovascular complications].
Delahaye JP; Pillot M; Delahaye F; Dubost A
Arch Mal Coeur Vaiss; 1991 Sep; 84 Spec No 3():117-21. PubMed ID: 1683221
[TBL] [Abstract][Full Text] [Related]
13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
14. [Hypertension and hyperlipidemia].
Hansen HS; Larsen ML
Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
[TBL] [Abstract][Full Text] [Related]
15. [Which optimal antihypertensive bitherapy for kidney patients?].
Bonne JF; Shahapuni I; Mailliez S; Oprisiu R; Temmar M; Choukroun G; Massy ZA; Fournier A
Nephrol Ther; 2007 Jun; 3(3):79-88. PubMed ID: 17540309
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
17. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
19. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
